The purpose of this study is to evaluate the use of intrathecal morphine administration following an unintentional dural puncture, to decrease the incidence of post dural puncture headaches (PDPH) in obstetric patients.
Unintentional dural puncture is a known risk of neuraxial techniques, occurring in roughly 1% of all epidural catheter placements. The incidence of post dural puncture headaches(PDPH) after unintentional dural puncture (UDP) is 50-80%. A PDPH is defined as a headache that occurs following a dural puncture, worsens within 15 minutes after sitting or standing and improves within 15 minutes after lying, with at least one of the following: neck stiffness, tinnitus, hypacusia, photophobia, or nausea. The headache develops within 5 days after dural puncture and resolves either spontaneously within 1 week or within 48 hours after effective treatment of the spinal fluid leak. The rates of PDPH following unintentional dural puncture with placement of an intrathecal catheter will be compared in two groups: intrathecal morphine (treatment) versus intrathecal saline (control) administered 1-2 hours after delivery, followed by immediate catheter removal. Patients randomized to the treatment group (morphine) will receive preservative-free morphine 0.3 mL (150 mcg) intrathecally. Those randomized to the control group will receive normal saline 0.3 mL intrathecally. After administration of intrathecal morphine, all patients will have their respirations monitored every hour for a period of 12 hours and then every two hours for a period of 12 hours. On postpartum days 1-5, all patients will be visited daily while inpatient and/or contacted by phone after discharge from the hospital. PDPH can lead to significant morbidity and negatively impact patient satisfaction with postpartum recovery. Along with headache, patients may develop cranial nerve palsy during the postpartum period leading to permanent disability. In addition, new mothers are unable to bond with their babies due to headache and associated symptoms of nausea, vomiting and limited mobility secondary to pain. Therefore, an effective intervention to decrease the risk of PDPH after UDP would be useful.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
68
The drug will be prepared in tuberculin syringes. After thoroughly sanitizing the catheter port with a Chloroprep wipe and allowing adequate time for drying of the Chloroprep, the anesthesiologist will first attach a 3-mL syringe to the catheter port and aspirate to a volume of 1 mL. This syringe will then be removed from the port. The study drug will then be administered through the intrathecal catheter via the tuberculin syringe. The 3-mL syringe containing the aspirate will then be injected via the catheter, effectively flushing the study drug through the catheter. The intrathecal catheter will be removed immediately following the injection.
The drug will be prepared in tuberculin syringes. After thoroughly sanitizing the catheter port with a Chloroprep wipe and allowing adequate time for drying of the Chloroprep, the anesthesiologist will first attach a 3-mL syringe to the catheter port and aspirate to a volume of 1 mL. This syringe will then be removed from the port. The study drug will then be administered through the intrathecal catheter via the tuberculin syringe. The 3-mL syringe containing the aspirate will then be injected via the catheter, effectively flushing the study drug through the catheter. The intrathecal catheter will be removed immediately following the injection.
Northwestern Memorial Hospital
Chicago, Illinois, United States
Participants Who Report Post Dural Puncture Headaches
Participants who report post dural puncture headaches from delivery to postpartum day 5
Time frame: 5 days
Severity of Post Dural Puncture Headache
Severity of post dural puncture headache on a numerical rating scale 0= no pain and 10= worst pain imaginable from the time of delivery to postpartum day 5.
Time frame: Time of unintentional dural puncture to postpartum day 5
Treatment Method for Headache
Treatment method completed for unintentional dural puncture headache.
Time frame: Unintentional dural puncture - Postpartum day 5
Number of Participants With Cranial Nerve Symptoms
The number of participants who experience cranial nerve symptoms up to 5 days after the unintentional dural puncture.
Time frame: 5 days
Repeat Epidural Blood Patch
Repeated epidural blood patch for headache pain after unintentional dural puncture.
Time frame: After first epidural blood patch to 5 days after delivery
Presenting Day of Headache
Presenting day of headache after unintentional dural puncture
Time frame: Dural puncture to 5 days after delivery
Number of Participants With Duration in Days of Headache After Unintentional Dural Puncture.
The duration in days of headaches the participants experience after an unintentional dural puncture
Time frame: 5 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Greatest Level of Headache Pain Experienced With the Unintentional Dural Puncture
Greatest reported headache pain associated with unintentional dural puncture reported on a scale of 0= no pain to 10= worst pain imaginable.
Time frame: 5 days
Intrathecal Catheter Dwell Time
Intrathecal catheter dwell time(time from insertion to time of removal in minutes).
Time frame: Insertion time to removal in minutes
Intrathecal Infusion Volume
Intrathecal infusion volume in milliliters
Time frame: Time of insertion of catheter to time catheter removed
Mode of Delivery
Mode of delivery of the baby (vaginal delivery or instrumented vaginal delivery)
Time frame: up to 10 hours after intrathecal catheter placed